T7 Ribonucleic Acid Polymerase-Triggered CRISPR/Cas13a and Branched HCR Cascade Amplification with Machine Learning for SERS Detection of Cardiac Troponin I
ACS Applied Materials & Interfaces · 11.11.2026 · 18 (44) · 61616-61628
DOI: 10.1021/acsami.6c17334 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 26.10.2026. Verfasst von Na Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Bioengineering, Xihua University, Chengdu610039, P R China. Hauptthemen laut MEDLINE: Troponin I, Machine Learning, CRISPR-Cas Systems, DNA-Directed RNA Polymerases. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Cardiac troponin I (cTnI) serves as a critical biomarker of acute myocardial infarction (AMI). Its serum level is extremely sparse, and the clinical cut-off value reaches merely 0.2 ng mL–1. This poses a significant challenge, requiring highly sensitive analytical techniques for reliable quantification. This study proposes a powerful surface-enhanced Raman scattering (SERS) sensing strategy integrating multistage signal amplification and machine learning to enhance detection performance. By combining T7 RNA polymerase, CRISPR/Cas13a, branched hybridization chain reaction (bHCR), and Fe3O4@COF@Ag magnetic substrate, the strategy constructs an efficient “recognition–amplification–signal output” closed loop for cTnI detection. Experimental results demonstrate that the platform has a linear calibration range of 0.1–104 pg/mL for cTnI, with an estimated limit of detection (LOD) of 0.1 pg/mL, holding promise for future AMI-related biomarker analysis. It also shows excellent selectivity against common serum interferents, good reproducibility (intra-batch RSD = 2.87%, inter-batch RSD = 7.96%), and reliable recovery (100.1%–110%) in human serum samples. Based on Raman signals, the k-nearest neighbor (kNN) classifier demonstrated high accuracy in classifying cTnI concentration levels, while the artificial neural network (ANN) model exhibited strong quantitative predictive performance with an R2 of 0.9997. This platform overcomes the limitations of conventional cTnI assays in terms of sensitivity and signal amplification efficiency, providing a promising analytical platform for future AMI-related biomarker studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Food and Bioengineering, Xihua University, Chengdu610039, P R China.
- Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Fudan University, Shanghai201399, P R China.
- Shanghai Institute of Doping Analyses, Shanghai University of Sport , Shanghai200438, P R China.
ORCID-Profile: Xiaojun Luo, Bing Shao
Förderung
- Science and Technology Department of Sichuan Province
Zitieren
APA
Zhou, N., Ma, Y., Wang, Y., Zhai, F., Li, Y., Luo, X., & Shao, B. (2026). T7 Ribonucleic Acid Polymerase-Triggered CRISPR/Cas13a and Branched HCR Cascade Amplification with Machine Learning for SERS Detection of Cardiac Troponin I. ACS Applied Materials & Interfaces, 18(44), 61616-61628. https://doi.org/10.1021/acsami.6c17334
Vancouver
Zhou N, Ma Y, Wang Y, Zhai F, Li Y, Luo X, et al. T7 Ribonucleic Acid Polymerase-Triggered CRISPR/Cas13a and Branched HCR Cascade Amplification with Machine Learning for SERS Detection of Cardiac Troponin I. ACS Applied Materials & Interfaces. 2026;18(44):61616-61628. doi:10.1021/acsami.6c17334
BibTeX
@article{Zhou2026,
author = {Zhou, Na and Ma, Yueyue and Wang, Yunxia and Zhai, Fuheng and Li, Yuanyuan and Luo, Xiaojun and Shao, Bing},
title = {T7 Ribonucleic Acid Polymerase-Triggered CRISPR/Cas13a and Branched HCR Cascade Amplification with Machine Learning for SERS Detection of Cardiac Troponin I},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {44},
pages = {61616--61628},
doi = {10.1021/acsami.6c17334}
}
EUVIMED